DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
D• V•••• P•••••••• C•••
Life Sciences Tools & Servicesgroup grade Aoff every schedule since Dec 31, 2024sponsor unattributed
Nothing material in the last 200 days. Last change: 31 Dec 2024, $57.9M principal held by 2 lenders; matures Jan 2027.
Mark path, consensus per quarter end
101¢ · 101¢ · 100¢ · 100¢ · 100¢Q4 2023 to Q4 2024
Where each lender marks it on the first lien term loan, 0 points apart
100¢100¢
Principal held
at least $57.9M
sum of BDC pieces, a lower bound
Fair value
$58.1M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Jan 1, 2027
no dated debt inside 24 months
On the tape since
Sep 30, 2023
latest Dec 31, 2024
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A••• S•••••••• I••••• F••• | $52.3M | 100¢ | 0 pts |
| G•••••• S•••• P•••••• C••••• C•••• | $5.6M | 100¢ | 0 pts |
Every BDC piece · 2 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A••• S•••••••• I••••• F••• | term loan first lien F•••• lien senior secured loan | $52.3M | $52.4M 100c | S+350 bp |
| G•••••• S•••• P•••••• C••••• C•••• | term loan first lien 1st L•••/S••••• S•••••• D••• I••••••• L••• S••••••• T•••• & Services I••••••• R••• 7.86% R | $5.6M | $5.6M 100c | SOFR+350 bp |
Capital structure as the BDCs see it
latest quarter end Dec 31, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Dec 31, 2024 | at least $57.9M | 100c | SOFR+350 bp | Jan 8, 2027 | 2 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2 | $57.9M | $58.1M | 100c | 0 |
| Sep 30, 2024 | 2 | $37.3M | $37.3M | 100c | 0 |
| Jun 30, 2024 | 1 | $1.3M | $1.3M | 100c | 0 |
| Mar 31, 2024 | 2 | $10.2M | $10.2M | 101c | 0 |
All 6 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2023 | 1 | $8.9M | $8.9M | 101c | 0 |
| Sep 30, 2023 | 2 | $7.9M | $7.8M | 100c | 0 |
What changed
- Facility left every BDC scheduleDec 31, 2024
- New borrower on a BDC scheduleSep 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- DA VINCIderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Life Sciences Tools & Servicesreportedas one filer wrote it